Sale of Lumus Imaging to Affinity Equity Partners
Filed with ASX · · 3 pages · English
Summary by 6ix AI
Healius Limited has announced the sale of its Lumus Imaging subsidiary to Affinity Equity Partners, as detailed in their recent ASX announcement. The transaction is valued at an enterprise amount and is expected to close in the first quarter of the following calendar year, pending certain conditions. Proceeds from the sale will be utilized to reduce debt and support strategic initiatives in Healius' Pathology division, while also returning cash to shareholders. Healius anticipates that this divestment will not negatively impact its remaining operations or earnings.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
In the deck
Earlier from Healius
- HLS FY24 Results Presentation
- HLS Release FY24 Results
- Preliminary Final Report
- Healius announces Trading Update for FY 2024
- Update on Strategic Review and Chair Appointment
Later from Healius
- Lumus Imaging Sale Presentation
- Chair's Address to Shareholders
- CEO Address to Shareholders
- Half Year 2025 Results Presentation
- Healius announces 1H 2025 results
Follow Healius into a list and get an email when it puts out news.
Follow Healius